Research by Jungnickel shows that IL-17C promotes neutrophilic inflammation in the tumor microenvironment and suggests that IL-17C links a pathologic microbiota, with enhanced tumor growth (Jungnickel et al., 2017). This evidence concerns the gene IL17C and neoplasm.